“EFFECT OF DAPAGLIFLOZIN, SITAGLIPTIN AND METFORMIN COMBINATION ON SOME METABLIC RISK FACTORS IN IRAQI PATIENTS WITH TYPE-2 DIABETES MELLITUS” (2024) Neuropsychopharmacologia Hungarica, 22(1), pp. 204–209. Available at: http://neuropsychopharmacologiahungarica.com/index.php/NPPH/article/view/17 (Accessed: 18 June 2024).